Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (7786)	6/3/1999 2:48:00 PM
From: manny t	Read Replies (2) \| Respond to of 9523

I posted the following on the Market Gems thread. To: lee kramer (43017 ) From: manny t Thursday, Jun 3 1999 1:44PM ET Reply # of 43031 PFE, Is anyone buying PFE for the 3 for 1 stock split on 6/30? At current price of PFE of 108,this would mean 36 dollars per share post split.Somehow it seems very cheap at the current price. 40 to 45 seems like a more likely post split price,or 120 to 135 pre-split. I am in. IMHO, Manny T.

To: Anthony Wong who wrote (7786)	6/3/1999 5:51:00 PM
From: Dan Spillane	Read Replies (1) \| Respond to of 9523

I hold stock in Cell Genesys (CEGE) which owns part of Abgenix; if mice can be drug factories like sheep, we are set. And it seems obvious they can at this point; there is already a tremendous amount of research which has gone into mice. (you posted) The companies, Abgenix Inc. <ABGX.O> and Medarex Inc. <MEDX.O>, have spent millions of dollars and years of research developing the mice, which are hot items among drug makers hoping to tap into what is expected to be a multibillion dollar industry of medicines based on antibodies.